Peter DeMuth - Sep 30, 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Chief Scientific Officer
Signature
/s/ Peter DeMuth
Stock symbol
ELTX
Transactions as of
Sep 30, 2024
Transactions value $
$0
Form type
4
Date filed
10/2/2024, 04:13 PM
Previous filing
Feb 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Stock Option (Right to Buy) Award $0 +29.8K $0.00 29.8K Sep 30, 2024 Common Stock 29.8K $5.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.